Interestingly, SOX2 expression was significantly higher in patients without lymph node metastasis as compared to their N+ counterparts (p = 0.047), and a clear trend of higher SOX2 expression in patients with a lower tumor stage (p = 0.067) was observed. The gene discussed is SOX2; the disease is neoplasm.